Patent ID: 6140356
Filing Date: 2000-10-31
Classification: A61K,A61P,C07C,C07D

Abstract:
An ophthalmic pharmaceutical composition comprising a pharmaceutically acceptable ophthalmic carrier and an ocular inflammation-treating amount of a compound of formula I: ##STR5## wherein each R.sup.1 is independently selected from the group consisting of alkyl, lower alkoxy, aminoacyl, acyloxy, hydroxy and --CO.sub.2 Y, wherein Y is hydrogen or a pharmaceutically acceptable salt;R.sup.2 is selected from the group consisting of hydrogen, alkyl and aryl;R.sup.3 is selected from the group consisting of alkyl, alkenyl, alkynyl, aryl, alkaryl, alkcycloalkyl, cycloalkyl and cycloalkenyl;X is CH; andn is an integer from 0 to 3.